Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 3Unknown 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Ovarian Neoplasms 1Hemangiosarcoma 1Gynecologic Cancer 1Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 77Docetaxel 69Capecitabine 64Trastuzumab 61Paclitaxel 50Tamoxifen 47Epirubicin 47Letrozole 44pyrotinib 40Fulvestrant 37Doxorubicin 35Vinorelbine 33Radiotherapy 32Carboplatin 32Anastrozole 28exemestane 27Neoadjuvant Therapy 24Drug Therapy 22Fluorouracil 21palbociclib 20Exercise 20Chemotherapy, Adjuvant 19Bevacizumab 18pertuzumab 16Goserelin 16Cisplatin 16liposomal doxorubicin 15Mammography 14Gemcitabine 14Blood Specimen Collection 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms × genexol-PM × Clear all
NCT01784120 2016-02-10

A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer

Gachon University Gil Medical Center

Phase 2 Unknown
48 enrolled
Breast

Breast Neoplasms

NCT00912639 2009-06-16

A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast Cancer

Korean Breast Cancer Study Group

Phase 4 Unknown
90 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡